-The Hindu Jalna (Maharashtra): An angry silence greets one on entering the village of Dhasalgaon in Jalna district. Perpetuating agrarian crises for the last three years have made the once-proud farmers of this village poor. Despite the newly elected Bharatiya Janata Party government's announcement that it seek a Rs. 4,500-crore package from the Centre, farmers in Jalna have wearied of the lip service that Mumbai's mandarins have been paying them for the...

-Economic and Political Weekly   The runaway growth in states of subsidised solar pumps, which provide quality energy at near-zero marginal cost, can pose a bigger threat of groundwater over-exploitation than free power has done so far. The best way to meet this threat is by paying farmers to "grow" solar power as a remunerative cash crop. Doing so can reduce pressure on aquifers, cut the subsidy burden on electricity companies, reduce...

-The Indian Express Prime Minister Narendra Modi has repeatedly promised India "maximum governance". But to get there, the high costs and ineffectiveness of frontline service providers need to be addressed. Take elementary school teachers, for instance. "Complete rest in comfortable conditions" is the description a rather candid elementary education cluster resource centre coordinator (CRCC) in Bihar gave his own job. And it's not just him, it is also how the CRCC describes...

-The Indian Express The aftermath of the terrible deaths of women who underwent sterilisation surgeries in Bilaspur in Chhattisgarh has been full of stories about what actually happened. Spurious drugs and an overenthusiastic doctor who cut corners on ensuring quality vie for immediate blame. Beyond these, many have spoken about pervasive biases of gender and caste that wreak havoc on the lives of poor women, and also of family planning policies...

-Business Standard Indian and other generic drug firms face prospect of US legislature debating compensation for undue price rises Indian generic drug makers might, if a proposed US law comes about, need to pay a rebate to the federal Medicaid programme there when prices of their medications outpace inflation. A Bill is to be introduced in the US Senate by a member, aimed to cushion the impact on taxpayers in this manner...